Are we facing a superbug apocalypse? Are we facing a superbug apocalypse? - the Antibiotic Paradox

Similar documents
Epidemiology and Economics of Antibiotic Resistance

Antimicrobial Resistance at human-animal interface in the Asia-Pacific Region

The European AMR Challenge - strategic views from the human perspective -

Multi-drug resistant microorganisms

The UK strategy for antimicrobial resistance (AMR) and its implications for research and development

2016/LSIF/FOR/004 Policies to Promote Patient Access to Innovative Treatments and Combat Antimicrobial Resistance

Tackling the need for new antibacterial drugs

Preventing and Responding to Antibiotic Resistant Infections in New Hampshire

Resistance and New Rules on Antibiotic Use in Agriculture

Antibiotic resistance is one of the biggest threats to global health, food security, and development today.

Impact of Antimicrobial Resistance on Human Health. Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

Antimicrobial resistance and the need for stewardship. Dr Nick Brown RCP Acute Medicine conference, 16 April 2018

Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly

Combating Antimicrobial Resistance: The Way Forward

Antimicrobial Resistance. The Case for Diagnostics to Better Direct Therapy

Antimicrobial Stewardship

Imagine. Multi-Drug Resistant Superbugs- What s the Big Deal? A World. Without Antibiotics. Where Simple Infections can be Life Threatening

Carbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S

Antibiotic resistance: the rise of the superbugs

Why should we care about multi-resistant bacteria? Clinical impact and

Resolution adopted by the General Assembly on 5 October [without reference to a Main Committee (A/71/L.2)]

The challenge of growing resistance

COPING WITH ANTIMICROBIAL RESISTANCE

REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT

Antimicrobial resistance (AMR): action plans implementation. Kamil Saytkulov February, Moscow

What is the problem? Latest data on antibiotic resistance

Introduction to antimicrobial resistance

IFMSA Policy Proposal Antimicrobial Resistance

Hosted by Dr. Benedetta Allegranzi, WHO Patient Safety Agency A Webber Training Teleclass

ANTIMICROBIAL RESISTANCE: GLOBAL BURDEN

Keeping Antibiotics Working: Nursing Leadership in Action

Antimicrobial Stewardship:

Pfizer Position on Antimicrobial Resistance Management. Kirill Tverskoy, Medical Director Pfizer Russia February 21, 2017

The Rise of Antibiotic Resistance: Is It Too Late?

22/10/2013. antibiotic resistance an ecological problem. this part of the session. an ecological perspective. selection pressure and evolution

Rise of the Superbugs: the end of antibiotics? Peter Lambert Life and Health Sciences Aston University

Antimicrobial Stewardship

Control of. Antimicrobial. Agri Food Sector. Jeffrey LeJeune, DVM, PhD

Antibiotic Stewardship in Human Health- Progress and Opportunities

Antimicrobial Cycling. Donald E Low University of Toronto

Global Strategies to Address AMR Carmem Lúcia Pessoa-Silva, MD, PhD Antimicrobial Resistance Secretariat

Global Action Plan on AMR and Follow up

AMR situation in Europe: Strategy and vision

Nosocomial Infections: What Are the Unmet Needs

Antimicrobial Resistance, yes we care! The European Joint Action

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Hot Topics in Antimicrobial Stewardship. Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital

Role of the general physician in the management of sepsis and antibiotic stewardship

Antimicrobial Resistance Update for Community Health Services

DSM Sinochem Pharmaceuticals From Gist to Sustainable Antibiotics

A Conversation with Dr. Steve Solomon and Dr. Jean Patel on Antimicrobial Resistance June 18 th, 2013

Jaipur Declaration on Antimicrobial Resistance

Antibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine. Mike Apley Kansas State University

Summary of the latest data on antibiotic consumption in the European Union

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose

Commercial Challenges: Perspectives from Big Pharma

Antibiotic resistance: how did we get here and what can we do? Peter Lambert LHS

Impact of NHS England Quality Indicators on Antimicrobial Resistance. Professor Alan Johnson National Infection Service Public Health England

Antibiotic Resistance in India

Other Enterobacteriaceae

3/1/2016. Antibiotics --When Less is More. Most Urgent Threats. Serious Threats

Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals

Birgit Ross Hospital Hygiene University Hospital Essen Essen, Germany. Should we screen for multiresistant gramnegative Bacteria?

Antimicrobial stewardship

Antibiotic Resistance. A global view. Katia ISKANDAR RPh, Pharm.D, MHS, AMES, PhD candidate

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

Antimicrobial Resistance Initiative

RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR

11/22/2016. Hospital-acquired Infections Update Disclosures. Outline. No conflicts of interest to disclose. Hot topics:

The Use of Procalcitonin to Improve Antibiotic Stewardship

OECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH. Michele Cecchini OECD Health Division

Carbapenemase-Producing Enterobacteriaceae (CPE)

Talk outline. History of resistance. The start of antibiotic resistance: Penicillin. Bacterial evolution vs mankind s ingenuity

Addressing Antimicrobial Resistance: Importance of a One Health Approach

Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship

Comments from The Pew Charitable Trusts re: Consultation on a draft global action plan to address antimicrobial resistance September 1, 2014

8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM

Norwegian policies to address antimicrobial resistance

Presenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update

Geriatric Mental Health Partnership

Council of the European Union Brussels, 13 June 2016 (OR. en)

Antimicrobial Resistance and Dentistry. LDC Officials Day 4 December 2015 Susie Sanderson

The Responsible and Prudent use of Antimicrobials on Irish Pig Farms. Denis Healy

Antimicrobial Stewardship/Statewide Antibiogram. Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Current Trends in Antimicrobial Resistance and Need for Antimicrobial Stewardship Among Urologists. Edward A. Stenehjem, MD

ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies

Disclosures. Principles of Antimicrobial Therapy. Obtaining an Accurate Diagnosis Obtain specimens PRIOR to initiating antimicrobials

Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics

Antibiotic Resistance and the Antibiotic Crisis

Preserving bacterial susceptibility Implementing Antimicrobial Stewardship Programs Debra A. Goff, Pharm.D., FCCP

Antimicrobial Stewardship Strategy: Antibiograms

Collecting and Interpreting Stewardship Data: Breakout Session

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Antibiotic Stewardship in the Neonatal Intensive Care Unit. Objectives. Background 4/20/2017. Natasha Nakra, MD April 28, 2017

The trinity of infection management: United Kingdom coalition statement

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE

Testimony of the Natural Resources Defense Council on Senate Bill 785

Transcription:

Are we facing a superbug apocalypse? 21ST CENTURY MEDICINE LECTURE SERIES: TODAY S RESEARCH, TOMORROW S HEALTHCARE Tackling infections, locally and globally www.sydney.edu.au/mbi Are we facing a superbug apocalypse? - the Antibiotic Paradox Don't it always seem to go That you don't know what you've got till it's gone Joni Mitchell (1970), Big Yellow Taxi From IDSA Capitol Hill talk by Brad Spellberg May 11 2010. www.idsociety.org/content.aspx?id=4810 fast forward to 2013 A post-antibiotic era means, in effect, an end to modern medicine as we know it Sep 28, 2013 US: 4.6% of global population, 46% of global ab market CDC: resistant organisms infections in >2 million, 23,000 deaths in US each year.. Some interventions, like hip replacements, organ transplants, cancer chemotherapy and care of preterm infants, would become far more difficult or even too dangerous to undertake Dr. Margaret Chan, director general WHO. March 16, 2012

Figure 1 Total outpatient antibiotic use in 26 European countries in 2002 AUS 132 days in hospital, 82 in ICU 12 operative procedures Blood stream infections: Enterobacter cloacae x 1 Enterobacter cloacae (ESBL) x 1 MRSA x 2 Pseudomonas aeruginosa x 2 A.baumannii (MRAB) x 2 Klebsiella pneumoniae (ESBL) x 1 Enterococcus faecalis x 1 Providencia sp x 1 Candida parapsilosis (yeast) x 1 Outcome measure 1: ICU: Patient survival = success ++ Outcome measure 2: ID/Micro: 130d: ICU, Burns. MRO exposure ++ Antibiotic use ++ = infection control disaster The Lancet Volume 365, Issue 9459 2005 579-587 the etiquette of antibiotic prescribing individual patient care approach just in case it is infection (defensive prescribing) risk of individual failure >> long-term loss of efficacy more antibiotics, longer duration, broader is safer vs. societal approach attempts to conserve antibiotics, stewardship avoid collateral selection (resistant organisms, C.difficile, ) against law of entropy? >50% antibiotic use in hospitals repeatedly shown to be inappropriate antibiotic resistance is Darwinian, BUT few new drugs in the development pipeline eg. 15/18 major pharma suppliers have left antibiotic field * Bartlett JG, Clin Infect Dis, 2013 http://www3.weforum.org/docs/wef_globalrisks_report_2013.pdf

one slide crash course about Superbugs??!! some bacteria are antibiotic susceptible but virulent, some are resistant but cause infection only in a small minority bacteria are part of our commensal flora. Staph on skin, E.coli as part of gut flora Gram (E.coli) also in other niches: animals, food, environment bacteria transfer genetic material very efficiently codes for resistant enzymes protect bacteria from antibiotics the more antibiotics inhibited, the more multiresistant some confer extreme resistance & risk of untreatable infection: ESBLs; CREs (NDM, KPC) THE BLACK PLAGUE Spread by merchants and travelers, the plague killed > 1/3 of Europe s population within 5 years eg. Staph eg. E.coli, Klebsiella https://qed.princeton.edu/index.php/user:peak/transclude CREs 2007 NYC 21% Klebsiella KPC+ NDM-1+ 2008 NDM-1: 2009-2011 Red Plague? KPC+ 1996 KPC+ 2003

Klebsiella pneumoniae in blood cultures resistant to 3rd Gen Cephalosporins (cefotaxime/ceftriaxone) Trends in MRSA and ESBL E.Coli bacteremia in Europe. Extrapolated EARSS nos for 2003 2009, and trajectories based on regression analysis for 2010 2015. 2011 2005 2.5 x 30 day & 2.9 x hospital mortality ESBL+ E.coli MRSA Data from EARSS, http://www.ecdc.europa.eu/activities/surveillance/ears-net/ de Kraker MEA, Davey PG, Grundmann H, PLoS Med 8(10) 2011. Resistant infections associated with higher rates of death, illness and prolonged hospital stay India makes ~ 1/3 world s antibiotics ($12.4 billion) 5,000+ manufacturers of generic antibiotics 23% of city dwellers have no toilets 2012 WHO report In 2007 ~45,000 cipro doses released daily downstream of Hyderabad sewage plant Jason Gale, Bloomberg Press, May 8, 2012 >100 million NDM-1 +ve in India Walsh et al, Lancet ID, 2011 Pakistan hospitals: 37% CRE+ Nahid F. J Inf Public Health 2013 171 environment swabs - 51/171 (29.8%) NDM-1+ 50 water samples - 2/50 (4%) NDM-1+ India has lost the war against the toughest forms of antibiotic resistance, largely because of poor sanitation, unregulated use of antibiotics and an absence of drug resistance monitoring

Ecology of food-borne organisms c/o Seamus Fanning, UCD Institute of Food and Health, Dublin Environment Rivers Land mass Streams Animal feeds offal drinking water Animals Cattle Poultry manure spreading Sheep Pigs farm effluents abattoirs processors meat handling processing consumption sea sewage Humans Urban swimming Rural Hospitalised contact Civilization is the distance man has placed between himself and his (or his animals ) excreta ~ Brian Aldiss, adapted mostly for growth promotion, despite no data for efficacy As we start to understand the gut microbiome, are we creating genetically modified animals? Source: PEW Charitable Trust ESBL rates in various types of meat - Netherlands 2011 Overdevest I. Emerg Infect Dis 2011 Solutions Smart companies and smart governments: leadership / governance / political will incentives to pharma diagnostics, rewarding innovation Behavioural: promote the special / fragile nature of antibiotics identify personal and societal triggers to behaviour change Structural: hospitals (eg. infection control), sanitation Organisational: engagement with all identified specialities, interest groups International: resistance does not respect borders Legislative: worldwide ban on non-therapeutic use in animals Sustained: the world has a short attention span

University of Sydney, Feb 7-8, 2011 Competition for government commitment Antibiotic resistance an intangible problem c/w obesity, cardiac disease, mental illness like climate change? seen as someone else s problem to tackle, even within medical specialities role of outside factors - can local investment turn things around without international commitment AMRSC, MBI Medical J Austr 2011. 194:281-3 Human infections one health research domains and themes multidisciplinary infection management and control Zoonotic infections Animal infections Field to laboratory to bedside Infection control and biosecurity Surveillance and response Policy and communication Education and outreach Environment and sustainability Plant and soil health exploring the role that universities can play in linking science to social and political action, stimulating innovation and access, and supporting research to shape the response to the challenges of antimicrobial resistance Behavioural aspects and drivers of antibiotic use Stewardship interventions hospital, community, veterinary Antibiotic use guidelines at local and national level Infection control initiatives Resistance surveillance Diagnostics: molecular detection of infection, resistance targets; New antimicrobial compounds Genetics of antibiotic resistance Biomarkers to differentiate viral from bacterial infection One health partnerships: veterinary and medicine International partnerships: education, capacity building The Broad Street Pump {in problems of antibiotic use}.. as in state affairs, by foreseeing them at a great distance, the evils which might arise from them are soon cured; - but when from want of foresight, they are suffered to increase to such a height that they are perceptible to everyone, there is no longer any remedy Niccolo Machiavelli in The Prince (1513)